Search Results

East Region Formulary ERFC Minutes 29 May 2024 Page 1 of 16 East Region Formulary Committee Minutes Date: 29 May 2024 Time: 2.00pm – 5.00pm Location: MS Teams Present: Jane Browning ...

East Region Formulary Prepared by C Satti October 2024 Checked by M Ross October 2024 Summary of updates to East Region Formulary (ERF) website. The purpose of this summary is to detail the main ...

East Region Formulary ERFC Minutes 07 August 2024 Page 1 of 19 East Region Formulary Committee Minutes Date: 07 August 2024 Time: 2.00pm – 4.45pm Location: MS Teams Present: Carla Capaldi ...

East Region Formulary ERFC Minutes 27 March 2024 Page 1 of 11 East Region Formulary Committee Minutes Date: 27 March 2024 Time: 2.00pm – 4.00pm Location: MS Teams Present: Carla Capaldi ...

SMC2592 : For the treatment of active moderate to severe hidradenitis suppurativa (HS) (acne inversa) in adults with an inadequate response to conventional systemic HS therapy. SMC restriction: for u...

1054/15 : Treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.

1159/16 : Treatment of active ankylosing spondylitis (AS) in adults who have responded inadequately to conventional therapy.

TA445 (SMC 1167/16) : Alone or in combination with methotrexate, for the treatment of active psoriatic arthritis in adult patients when the response to previous disease-modifying anti-rheumatic drug (...

SMC2308 : For the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging ...